2005 ASH Scholar Award Winners
Congratulations to the following individuals – they will begin their awards on July 1, 2005.
Basic Research Fellows
Marie-Dominique Filippi, Ph.D.
Cincinnati Children’s Hospital
The role of CFC42 in neutrophil functions
M. Golan Mohi, Ph.D.
Beth Israel Deaconess Medical Center
Shp2 Mutations in Human Leukemia
Laurent Mosnier, Ph.D.
The Scripps Research Institute
Mechanisms for cytoprotective actions of activated protein C
David Motto, M.D., Ph.D.
University of Michigan
Functional analysis of ADAMTS13 in the mouse
Matthew Walter, M.D.
Washington University
Genetic progression events in murine APL
Clinical/Translational Research Fellows
Neil Goldenberg, M.D.
University of Colorado Health Sciences Center
Prophylaxis for catheter-related infection and thrombosis in children with cancer (the PediCathClot Trial)
Kimberly Stegmaier, M.D. (ASH-Wallace H. Coulter Foundation Scholar)
Dana-Farber Cancer Institute
Induction of AML Differentiation via Gene Expression-based High Throughout Screening (GE-HTS)
Roland Walter, M.D.
Fred Hutchinson Cancer Research Center
Regulation of ITIM-dependent internalization of CD33, the target for the anti-leukemia immunoconjugate, gemtuzumab ozogamicin (Mylotarg)
Basic Research Junior Faculty
Alan Cantor, M.D., Ph.D.
Children’s Hospital Boston
Transcriptional regulation of megakaryopoiesis
Min Chen, Ph.D.
Baylor College of Medicine
The role of PTEN phosphatase in regulating dendritic cell apoptosis and function
Richard Dahl, Ph.D.
University of New Mexico
The role of the PU.1 to Gfi-1 ratio in directing hematopoietic differentiation
Boris Reizis, Ph.D.
Columbia University
Regulation of plasmacytoid dendritic cell development and function
Clinical/Translational Research Junior Faculty
Jorge DiMartino, M.D., Ph.D.
Cincinnati Children’s Hospital
Development of a human in vitro model of leukemia induced by chimeric Mll oncoproteins for the pre-clinical evaluation of DNA methylthransferase
Irene Ghobrial, M.D.
University of Pittsburgh
Study of the P13K pathway in non-Hodgkin lymphoma
Xianzheng Zhou, M.D., Ph.D.
University of Minnesota
Identification of MHC class II restricted male-specific minor histocompatability antigens


